What is a common drug interaction concern when a patient on beta-blockers receives a vasopressor during anesthesia?

What is a common drug interaction concern when a patient on beta-blockers receives a vasopressor during anesthesia?

• A. Unopposed beta-adrenergic effects can cause severe tachycardia.
• B. Unopposed alpha-adrenergic effects can cause severe hypertension; prefer vasopressors with balanced alpha/beta activity (e.g., norepinephrine) and monitor closely.
• C. Vasopressors will always overcome beta-blockade with no adverse effects.
• D. Beta-blockers neutralize vasopressor effects.

Answer: (B)

When beta receptors are blocked, the vasopressor’s alpha effects can dominate because there’s no beta-mediated counterbalance. Pure alpha-adrenergic vasoconstriction (like certain vasopressors) can produce severe hypertension and increased afterload, while the heart cannot compensate by increasing rate or contractility due to the beta-blockade. The safer approach is a vasopressor with both alpha and beta activity, such as norepinephrine, which raises vascular tone but still provides some beta-1 stimulation to support cardiac output. Close monitoring is essential to titrate effects and avoid ischemia or excessive afterload.

When beta receptors are blocked, the vasopressor’s alpha effects can dominate because there’s no beta-mediated counterbalance. Pure alpha-adrenergic vasoconstriction (like certain vasopressors) can produce severe hypertension and increased afterload, while the heart cannot compensate by increasing rate or contractility due to the beta-blockade. The safer approach is a vasopressor with both alpha and beta activity, such as norepinephrine, which raises vascular tone but still provides some beta-1 stimulation to support cardiac output. Close monitoring is essential to titrate effects and avoid ischemia or excessive afterload.